-
-
-
-
-
-
-
Apogee Therapeutics board to lose two directors in May
-
-
-
-
-
-
-
Mizuho on Apogee Therapeutics Inc (APGE): data shows potential 'best-in-indication biologic efficacy and convenience'
-
-
-
-
-
-
-
Apogee Therapeutics Inc (APGE) PT Raised to $95 at Wedbush
-
-
-
-
-
-
-
Wolfe Research Starts Apogee Therapeutics Inc (APGE) at Peerperform
-
-
-
-
-
-
-
Where can biotech stocks go from here? RBC answers
-
-
-
-
-
-
-
RBC Capital Starts Apogee Therapeutics Inc (APGE) at Outperform
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

